메뉴 건너뛰기




Volumn 55, Issue 11, 2006, Pages 1443-1450

Non-viral in vivo immune gene therapy of cancer: Combined strategies for treatment of systemic disease

Author keywords

B7 1; Electroporation; Gene therapy; GM CSF; Immunotherapy; Non viral

Indexed keywords

B7 ANTIGEN; CD27 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; PROTEIN P53; VIRUS VECTOR;

EID: 33746901204     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-006-0169-z     Document Type: Conference Paper
Times cited : (22)

References (49)
  • 1
    • 0031753867 scopus 로고    scopus 로고
    • Gene transfer into muscle by electroporation in vivo
    • Aihara H, Miyazaki J (1998) Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16(9):867-870
    • (1998) Nat Biotechnol , vol.16 , Issue.9 , pp. 867-870
    • Aihara, H.1    Miyazaki, J.2
  • 2
    • 14744268262 scopus 로고    scopus 로고
    • CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2
    • Antony PA, Restifo NP (2005) CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother 28(2):120-128
    • (2005) J Immunother , vol.28 , Issue.2 , pp. 120-128
    • Antony, P.A.1    Restifo, N.P.2
  • 3
    • 0036005892 scopus 로고    scopus 로고
    • GM-CSF-based cellular vaccines: A review of the clinical experience
    • Borrello I, Pardoll D (2002) GM-CSF-based cellular vaccines: a review of the clinical experience. Cytokine Growth Factor Rev 13(2):185-193
    • (2002) Cytokine Growth Factor Rev , vol.13 , Issue.2 , pp. 185-193
    • Borrello, I.1    Pardoll, D.2
  • 4
    • 0344153890 scopus 로고    scopus 로고
    • CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination
    • Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, Melero I, Prieto J, Borras-Cuesta F, Lasarte JJ (2003) CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J Immunol 171(11):5931-5939
    • (2003) J Immunol , vol.171 , Issue.11 , pp. 5931-5939
    • Casares, N.1    Arribillaga, L.2    Sarobe, P.3    Dotor, J.4    Lopez-Diaz De Cerio, A.5    Melero, I.6    Prieto, J.7    Borras-Cuesta, F.8    Lasarte, J.J.9
  • 5
    • 0027078670 scopus 로고
    • Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
    • Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71(7):1093-1102
    • (1992) Cell , vol.71 , Issue.7 , pp. 1093-1102
    • Chen, L.1    Ashe, S.2    Brady, W.A.3    Hellstrom, I.4    Hellstrom, K.E.5    Ledbetter, J.A.6    McGowan, P.7    Linsley, P.S.8
  • 6
    • 0027982995 scopus 로고
    • Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity
    • Chen L, McGowan P, Ashe S, Johnston J, Li Y, Hellstrom I, Hellstrom KE (1994) Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med 179(2):523-532
    • (1994) J Exp Med , vol.179 , Issue.2 , pp. 523-532
    • Chen, L.1    McGowan, P.2    Ashe, S.3    Johnston, J.4    Li, Y.5    Hellstrom, I.6    Hellstrom, K.E.7
  • 7
    • 0027946018 scopus 로고
    • B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum
    • Chen L, McGowan P, Ashe S, Johnston JV, Hellstrom I, Hellstrom KE (1994) B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. Cancer Res 54(20):5420-5423
    • (1994) Cancer Res , vol.54 , Issue.20 , pp. 5420-5423
    • Chen, L.1    McGowan, P.2    Ashe, S.3    Johnston, J.V.4    Hellstrom, I.5    Hellstrom, K.E.6
  • 11
    • 1642546952 scopus 로고    scopus 로고
    • Enhancing CTL responses to melanoma cell vaccines in vivo: Synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells
    • Dezfouli S, Hatzinisiriou I, Ralph SJ (2003) Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells. Immunol Cell Biol 81(6):459-471
    • (2003) Immunol Cell Biol , vol.81 , Issue.6 , pp. 459-471
    • Dezfouli, S.1    Hatzinisiriou, I.2    Ralph, S.J.3
  • 12
    • 0027538181 scopus 로고
    • Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
    • USA
    • Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90(8):3539-3543
    • (1993) Proc Natl Acad Sci , vol.90 , Issue.8 , pp. 3539-3543
    • Dranoff, G.1    Jaffee, E.2    Lazenby, A.3    Golumbek, P.4    Levitsky, H.5    Brose, K.6    Jackson, V.7    Hamada, H.8    Pardoll, D.9    Mulligan, R.C.10
  • 13
    • 0033586324 scopus 로고    scopus 로고
    • Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models
    • Emtage PC, Wan Y, Hitt M, Graham FL, Muller WJ, Zlotnik A, Gauldie J (1999) Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models. Hum Gene Ther 10(5):697-709
    • (1999) Hum Gene Ther , vol.10 , Issue.5 , pp. 697-709
    • Emtage, P.C.1    Wan, Y.2    Hitt, M.3    Graham, F.L.4    Muller, W.J.5    Zlotnik, A.6    Gauldie, J.7
  • 14
    • 2342501737 scopus 로고    scopus 로고
    • CD4+ T cells cross-compete for MHC class II-restricted peptide antigen complexes on the surface of antigen presenting cells
    • Hayball JD, Robinson BW, Lake RA (2004) CD4+ T cells cross-compete for MHC class II-restricted peptide antigen complexes on the surface of antigen presenting cells. Immunol Cell Biol 82(2):103-111
    • (2004) Immunol Cell Biol , vol.82 , Issue.2 , pp. 103-111
    • Hayball, J.D.1    Robinson, B.W.2    Lake, R.A.3
  • 15
    • 0034536936 scopus 로고    scopus 로고
    • In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity
    • Heller L, Pottinger C, Jaroszeski MJ, Gilbert R, Heller R (2000) In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity. Melanoma Res 10(6):577-583
    • (2000) Melanoma Res , vol.10 , Issue.6 , pp. 577-583
    • Heller, L.1    Pottinger, C.2    Jaroszeski, M.J.3    Gilbert, R.4    Heller, R.5
  • 16
    • 30344481357 scopus 로고    scopus 로고
    • Oral immune tolerance mediated by suppressor T cells may be responsible for the poorer prognosis of foregut cancers
    • Larkin J, Tangney M, Collins C, Casey G, O'Brien MG, Soden D, O'Sullivan GC (2006) Oral immune tolerance mediated by suppressor T cells may be responsible for the poorer prognosis of foregut cancers. Med Hypotheses 66(3):541-544
    • (2006) Med Hypotheses , vol.66 , Issue.3 , pp. 541-544
    • Larkin, J.1    Tangney, M.2    Collins, C.3    Casey, G.4    O'Brien, M.G.5    Soden, D.6    O'Sullivan, G.C.7
  • 17
    • 0027403299 scopus 로고
    • The role of the CD28 receptor during T cell responses to antigen
    • Linsley PS, Ledbetter JA (1993) The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191-212
    • (1993) Annu Rev Immunol , vol.11 , pp. 191-212
    • Linsley, P.S.1    Ledbetter, J.A.2
  • 18
    • 0025322552 scopus 로고
    • T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1
    • USA
    • Linsley PS, Clark EA, Ledbetter JA (1990) T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 87(13):5031-5035
    • (1990) Proc Natl Acad Sci , vol.87 , Issue.13 , pp. 5031-5035
    • Linsley, P.S.1    Clark, E.A.2    Ledbetter, J.A.3
  • 19
    • 0025219689 scopus 로고
    • Dormancy and breast cancer
    • Meltzer A (1990) Dormancy and breast cancer. J Surg Oncol 43(3):181-188
    • (1990) J Surg Oncol , vol.43 , Issue.3 , pp. 181-188
    • Meltzer, A.1
  • 20
    • 30744448160 scopus 로고    scopus 로고
    • T cells targeted against a single minor histocompatibility antigen can cure solid tumors
    • Meunier MC, Delisle JS, Bergeron J, Rineau V, Baron C, Perreault C (2005) T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med 11(11):1222-1229
    • (2005) Nat Med , vol.11 , Issue.11 , pp. 1222-1229
    • Meunier, M.C.1    Delisle, J.S.2    Bergeron, J.3    Rineau, V.4    Baron, C.5    Perreault, C.6
  • 21
    • 0035985655 scopus 로고    scopus 로고
    • Cancer vaccines, a critical review - Part I
    • Mitchell MS (2002) Cancer vaccines, a critical review - Part I. Curr Opin Investig Drugs 3(1):140-149
    • (2002) Curr Opin Investig Drugs , vol.3 , Issue.1 , pp. 140-149
    • Mitchell, M.S.1
  • 22
    • 0032401860 scopus 로고    scopus 로고
    • EblacZ tumor dormancy in bone marrow and lymph nodes: Active control of proliferating tumor cells by CD8+ immune T cells
    • Muller M, Gounari F, Prifti S, Hacker HJ, Schirrmacher V, Khazaie K (1998) EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells. Cancer Res 58(23):5439-5446
    • (1998) Cancer Res , vol.58 , Issue.23 , pp. 5439-5446
    • Muller, M.1    Gounari, F.2    Prifti, S.3    Hacker, H.J.4    Schirrmacher, V.5    Khazaie, K.6
  • 23
    • 0037172969 scopus 로고    scopus 로고
    • CD25+CD4+ T cells contribute to the control of memory CD8+ T cells
    • USA
    • Murakami M, Sakamoto A, Bender J, Kappler J, Marrack P (2002) CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci USA 99(13):8832-8837
    • (2002) Proc Natl Acad Sci , vol.99 , Issue.13 , pp. 8832-8837
    • Murakami, M.1    Sakamoto, A.2    Bender, J.3    Kappler, J.4    Marrack, P.5
  • 24
    • 0033638189 scopus 로고    scopus 로고
    • The inflammatory response within Dukes' B colorectal cancers: Implications for progression of micrometastases and patient survival
    • Murphy J, O'Sullivan GC, Lee G, Madden M, Shanahan F, Collins JK, Talbot IC (2000) The inflammatory response within Dukes' B colorectal cancers: implications for progression of micrometastases and patient survival. Am J Gastroenterol 95(12):3607-3614
    • (2000) Am J Gastroenterol , vol.95 , Issue.12 , pp. 3607-3614
    • Murphy, J.1    O'Sullivan, G.C.2    Lee, G.3    Madden, M.4    Shanahan, F.5    Collins, J.K.6    Talbot, I.C.7
  • 25
    • 0032996037 scopus 로고    scopus 로고
    • Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: Suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
    • Nasu Y, Bangma CH, Hull GW, Lee HM, Hu J, Wang J, McCurdy MA, Shimura S, Yang G, Timme TL, Thompson TC (1999) Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther 6(3):338-349
    • (1999) Gene Ther , vol.6 , Issue.3 , pp. 338-349
    • Nasu, Y.1    Bangma, C.H.2    Hull, G.W.3    Lee, H.M.4    Hu, J.5    Wang, J.6    McCurdy, M.A.7    Shimura, S.8    Yang, G.9    Timme, T.L.10    Thompson, T.C.11
  • 27
    • 0020339802 scopus 로고
    • Gene transfer into mouse lyoma cells by electroporation in high electric fields
    • Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. Embo J 1(7):841-845
    • (1982) Embo J , vol.1 , Issue.7 , pp. 841-845
    • Neumann, E.1    Schaefer-Ridder, M.2    Wang, Y.3    Hofschneider, P.H.4
  • 28
    • 0033018370 scopus 로고    scopus 로고
    • The Fas counterattack: Cancer as a site of immune privilege
    • O'Connell J (1999) The Fas counterattack: cancer as a site of immune privilege. Immunol Today 20(1):46-52
    • (1999) Immunol Today , vol.20 , Issue.1 , pp. 46-52
    • O'Connell, J.1
  • 29
    • 0029808372 scopus 로고    scopus 로고
    • The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
    • O'Connell J, O'Sullivan GC, Collins JK, Shanahan F (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184(3):1075-1082
    • (1996) J Exp Med , vol.184 , Issue.3 , pp. 1075-1082
    • O'Connell, J.1    O'Sullivan, G.C.2    Collins, J.K.3    Shanahan, F.4
  • 30
  • 31
    • 0030588698 scopus 로고    scopus 로고
    • Regional immunosuppression in esophageal squamous cancer: Evidence from functional studies with matched lymph nodes
    • O'Sullivan GC, Corbett AR, Shanahan F, Collins JK (1996) Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes. J Immunol 157(10):4717-4720
    • (1996) J Immunol , vol.157 , Issue.10 , pp. 4717-4720
    • O'Sullivan, G.C.1    Corbett, A.R.2    Shanahan, F.3    Collins, J.K.4
  • 32
    • 0031011135 scopus 로고    scopus 로고
    • Micrometastases: Marker of metastatic potential or evidence of residual disease?
    • O'Sullivan GC, Collins JK, Kelly J, Morgan J, Madden M, Shanahan F (1997) Micrometastases: marker of metastatic potential or evidence of residual disease? Gut 40(4):512-515
    • (1997) Gut , vol.40 , Issue.4 , pp. 512-515
    • O'Sullivan, G.C.1    Collins, J.K.2    Kelly, J.3    Morgan, J.4    Madden, M.5    Shanahan, F.6
  • 34
    • 0033168037 scopus 로고    scopus 로고
    • Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody
    • Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59(13):3128-3133
    • (1999) Cancer Res , vol.59 , Issue.13 , pp. 3128-3133
    • Onizuka, S.1    Tawara, I.2    Shimizu, J.3    Sakaguchi, S.4    Fujita, T.5    Nakayama, E.6
  • 36
    • 1842768380 scopus 로고    scopus 로고
    • China approves first gene therapy
    • Pearson S, Jia H, Kandachi K (2004) China approves first gene therapy. Nat Biotechnol 22(1):3-4
    • (2004) Nat Biotechnol , vol.22 , Issue.1 , pp. 3-4
    • Pearson, S.1    Jia, H.2    Kandachi, K.3
  • 37
    • 0028343870 scopus 로고
    • T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells
    • Ramarathinam L, Castle M, Wu Y, Liu Y (1994) T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J Exp Med 179(4):1205-1214
    • (1994) J Exp Med , vol.179 , Issue.4 , pp. 1205-1214
    • Ramarathinam, L.1    Castle, M.2    Wu, Y.3    Liu, Y.4
  • 38
    • 0034670157 scopus 로고    scopus 로고
    • The role of CpG motifs in immunostimulation and gene therapy
    • Scheule RK (2000) The role of CpG motifs in immunostimulation and gene therapy. Adv Drug Deliv Rev 44(2-3):119-134
    • (2000) Adv Drug Deliv Rev , vol.44 , Issue.2-3 , pp. 119-134
    • Scheule, R.K.1
  • 39
    • 0036597371 scopus 로고    scopus 로고
    • CD4+ CD25+ suppressor T cells: More questions than answers
    • Shevach EM (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2(6):389-400
    • (2002) Nat Rev Immunol , vol.2 , Issue.6 , pp. 389-400
    • Shevach, E.M.1
  • 40
    • 0033571105 scopus 로고    scopus 로고
    • Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity
    • Shimizu J, Yamazaki S, Sakaguchi S. (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163(10):5211-5218
    • (1999) J Immunol , vol.163 , Issue.10 , pp. 5211-5218
    • Shimizu, J.1    Yamazaki, S.2    Sakaguchi, S.3
  • 42
    • 0035893387 scopus 로고    scopus 로고
    • Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T cell-dependent immune defense of B16 melanoma
    • Steitz J, Bruck J, Lenz J, Knop J, Tuting T (2001) Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T cell-dependent immune defense of B16 melanoma. Cancer Res 61(24):8643-8646
    • (2001) Cancer Res , vol.61 , Issue.24 , pp. 8643-8646
    • Steitz, J.1    Bruck, J.2    Lenz, J.3    Knop, J.4    Tuting, T.5
  • 43
    • 0032503016 scopus 로고    scopus 로고
    • Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine
    • Thomas MC, Greten TF, Pardoll DM, Jaffee EM (1998) Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine. Hum Gene Ther 9(6):835-843
    • (1998) Hum Gene Ther , vol.9 , Issue.6 , pp. 835-843
    • Thomas, M.C.1    Greten, T.F.2    Pardoll, D.M.3    Jaffee, E.M.4
  • 44
    • 0028646191 scopus 로고
    • Specificity and longevity of antitumor immune responses induced by B7-transfected tumors
    • Townsend SE, Su FW, Atherton JM, Allison JP (1994) Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res 54(24):6477-6483
    • (1994) Cancer Res , vol.54 , Issue.24 , pp. 6477-6483
    • Townsend, S.E.1    Su, F.W.2    Atherton, J.M.3    Allison, J.P.4
  • 46
    • 1642497640 scopus 로고    scopus 로고
    • Tumor-specific human CD4+ regulatory T cells and their ligands: Implications for immunotherapy
    • Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF (2004) Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20(1):107-118
    • (2004) Immunity , vol.20 , Issue.1 , pp. 107-118
    • Wang, H.Y.1    Lee, D.A.2    Peng, G.3    Guo, Z.4    Li, Y.5    Kiniwa, Y.6    Shevach, E.M.7    Wang, R.F.8
  • 47
    • 0742321751 scopus 로고    scopus 로고
    • Anti-tumor immunity and autoimmunity: A balancing act of regulatory T cells
    • Wei WZ, Morris GP, Kong YC (2004) Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells. Cancer Immunol Immunother 53(2):73-78
    • (2004) Cancer Immunol Immunother , vol.53 , Issue.2 , pp. 73-78
    • Wei, W.Z.1    Morris, G.P.2    Kong, Y.C.3
  • 48
    • 15444377017 scopus 로고    scopus 로고
    • Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors
    • Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu YX (2005) Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 201(5):779-791
    • (2005) J Exp Med , vol.201 , Issue.5 , pp. 779-791
    • Yu, P.1    Lee, Y.2    Liu, W.3    Krausz, T.4    Chong, A.5    Schreiber, H.6    Fu, Y.X.7
  • 49
    • 16844379997 scopus 로고    scopus 로고
    • Immunosuppressive networks in the tumour environment and their therapeutic relevance
    • Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5(4):263-274
    • (2005) Nat Rev Cancer , vol.5 , Issue.4 , pp. 263-274
    • Zou, W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.